MedPath

Cromolyn Sodium

PRESCRIBING INFORMATION

Approved
Approval ID

476a6d06-36a2-4935-b061-6d54498eeca8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 14, 2023

Manufacturers
FDA

Ailex Pharmaceuticals, LLC

DUNS: 080190901

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cromolyn Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70556-102
Application NumberANDA209453
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cromolyn Sodium
Product Specifications
Route of AdministrationINTRABRONCHIAL
Effective DateAugust 14, 2023
FDA Product Classification

INGREDIENTS (2)

CROMOLYN SODIUMActive
Quantity: 20 mg in 2 mL
Code: Q2WXR1I0PK
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cromolyn Sodium - FDA Drug Approval Details